TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07436156: SUMMIT RISE Study of Acute Ischemic Stroke Patients

Sponsor: Route 92 Medical, Inc. · Phase: PHASE4 · Area: CNS_NEUROLOGY · Target Enrollment: 500 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$9,932,800

Rescue Site Savings

+$6,549,440

Unlock Full NCT07436156 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07436156 Rescue Dossier →